does medical cover glp 1 for weight loss in california Medicaid fuels US coverage of Novo, Lilly weight-loss drugs Navigating Insurance Coverage for GLP-1

1 The findings showed: Those not taking GLP-1 medications showed significantly more MS disease progression Higher risk of brainstem dysfunction (4.36% risk difference) Higher risk of cerebellar dysfunction (4.54% risk difference) Higher risk of bowel and bladder dysfunction (4.98% risk difference) As a retrospective analysis, this study has limitations including potential confounding factors, and definitive randomised controlled trials are needed to confirm any disease-modifying effects of GLP-1 medications in MS

Its crucial not to overdo it

Immunology 155:407417

Getting ready to order my refill

Janciauskiene S, Welte T